ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

AACR Receives Record Number of Abstracts

January 27, 1989

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008